BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

FHLCvsIHEETF Comparison

ETF 1

FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of

US Health Care

+0.14%

Full FHLC fund page

VS

ETF 2

IHE

iShares U.S. Pharmaceuticals ETF

This fund is part of

US Health Care

+0.14%

Full IHE fund page

Fidelity MSCI Health Care Index ETF (FHLC) and iShares U.S. Pharmaceuticals ETF (IHE) belong to the same industry segment: US Health Care. FHLC's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, IHE's top sector exposures are Healthcare and Non-Corporate. FHLC is less expensive with a Total Expense Ratio (TER) of 0.084%, versus 0.37% for IHE. FHLC is up 16.94% year-to-date (YTD) with +$478M in YTD flows. IHE performs better with 22.39% YTD performance, and +$500M in YTD flows. Run a side-by-side ETF comparison of FHLC and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

FHLC vs IHE performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 10/26/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	FHLC IHE	+3.76%-0.27%	+8.83%+0.16%	+16.94%+22.39%	+23.63%+39.04%	+53.42%+90.47%	+39.86%+79.32%
Flows	FHLC IHE	+$77M-$124M	+$226M-$41M	+$478M+$500M	+$542M+$664M	-$184M+$689M	+$18M+$754M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	FHLC IHE	+17.04%+18.73%	+15.91%+18.70%	+14.92%+17.22%	+15.51%+16.78%
Max drawdown	FHLC IHE	-5.64%-9.67%	-10.35%-9.67%	-16.88%-16.04%	-17.78%-16.12%
Max drawdown duration	FHLC IHE	56d68d	169d68d	435d210d	762d669d

Trading data

Create an account to view trading data

Join for free

	FHLC	IHE
Last sale 10/27/2026 at 1:30 PM	$86.08	$103.35
Previous close 10/26/2026	$86.00	$102.81
Consolidated volume 10/26/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of September 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	FHLC	IHE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 10/27/2026 at 1:30 PM

Live

Closed

	FHLC	IHE
Last price	$86.08	$103.35
1D performance	+0.09%	+0.53%
AuM	$3.82 B	$1.54 B
E/R	0.084%	0.37%

Characteristics

	FHLC	IHE
Management strategy	Passive	Passive
Provider	Fidelity	iShares
Benchmark	MSCI USA IMI Health Care 25/50 Index	Dow Jones U.S. Select Pharmaceuticals Index
N° of holdings	338	57
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	October 21, 2013	May 1, 2006
ESG	No	No

More FHLC data on Trackinsight

More IHE data on Trackinsight

Exposure

Countries

FHLC

USA

97.14%

Other

2.86%

IHE

USA

95.75%

Other

4.25%

Sectors

FHLC

Healthcare

98.23%

Other

1.77%

IHE

Healthcare

99.75%

Other

0.25%

Diversification

FHLC

Total weight of top 15 holdings out of 15

60.85%

IHE

Total weight of top 15 holdings out of 15

84.42%

Top 15 holdings

Data as of August 31, 2026

FHLC

Eli Lilly & Co.

12.94%

Johnson & Johnson

8.88%

AbbVie, Inc.

6.21%

Merck & Co., Inc.

5.04%

UnitedHealth Group, Inc.

4.91%

Amgen, Inc.

3.21%

Thermo Fisher Scientific, Inc.

3.19%

Abbott Laboratories

2.69%

Gilead Sciences, Inc.

2.49%

Pfizer Inc.

2.19%

Vertex Pharmaceuticals, Inc.

1.90%

Danaher Corp.

1.89%

Bristol Myers Squibb Co.

1.87%

Intuitive Surgical, Inc.

1.82%

CVS Health Corp.

1.63%

IHE

Johnson & Johnson

22.45%

Eli Lilly & Co.

20.50%

Merck & Co., Inc.

5.00%

Bristol Myers Squibb Co.

4.84%

Royalty Pharma Plc

4.54%

Pfizer Inc.

4.48%

Viatris, Inc.

4.19%

Zoetis, Inc.

3.82%

Jazz Pharmaceuticals Plc

3.43%

Elanco Animal Health, Inc.

2.61%

Corcept Therapeutics, Inc.

2.36%

Crinetics Pharmaceuticals, Inc.

1.95%

Axsome Therapeutics, Inc.

1.87%

Ligand Pharmaceuticals, Inc.

1.24%

Definium Therapeutics, Inc.

1.12%

Frequently asked questions about FHLC and IHE

How have the FHLC and IHE ETFs performed in 2026?

As of October 26, 2026, FHLC is up 16.94% year-to-date (YTD), while IHE has returned 22.39%. That puts IHE better performer ahead so far this year.

Which ETF is attracting more investor money: FHLC or IHE?

Year-to-date, the FHLC ETF saw +$478M in flows, compared to +$500M for IHE.

Which ETF is more volatile: FHLC or IHE?

Over the past year, FHLC had a volatility of 15.91%, while IHE experienced 18.7%.

Which ETF is bigger: FHLC or IHE?

As of October 26, 2026, FHLC holds $3.82 B in assets under management (AUM), while IHE manages $1.54 B.

What sectors do the FHLC and IHE ETFs invest in?

FHLC leans toward sectors like Healthcare. Meanwhile, IHE focuses on Healthcare.

What are the top holdings of the FHLC ETF and IHE ETF?

FHLC top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. IHE holds in its top three: Johnson & Johnson, Eli Lilly & Co. and Merck & Co., Inc..

FHLCvsIHEETF Comparison

Fidelity MSCI Health Care Index ETF

iShares U.S. Pharmaceuticals ETF

FHLC vs IHE performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the FHLC and IHE ETFs performed in 2026?

As of October 26, 2026, FHLC is up 16.94% year-to-date (YTD), while IHE has returned 22.39%. That puts IHE better performer ahead so far this year.

Which ETF is attracting more investor money: FHLC or IHE?

Year-to-date, the FHLC ETF saw +$478M in flows, compared to +$500M for IHE.

Which ETF is more volatile: FHLC or IHE?

Over the past year, FHLC had a volatility of 15.91%, while IHE experienced 18.7%.

Which ETF is bigger: FHLC or IHE?

As of October 26, 2026, FHLC holds $3.82 B in assets under management (AUM), while IHE manages $1.54 B.

What sectors do the FHLC and IHE ETFs invest in?

FHLC leans toward sectors like Healthcare. Meanwhile, IHE focuses on Healthcare.

What are the top holdings of the FHLC ETF and IHE ETF?

FHLC top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. IHE holds in its top three: Johnson & Johnson, Eli Lilly & Co. and Merck & Co., Inc..

Which ETF is more diversified: FHLC or IHE?

FHLC holds 338 securities with 60.85% of its assets in the top 15. IHE has 57 securities and a top 15 weight of 84.42%.

Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze

Healthcare Stocks Rebound

Health is Wealth: A look at the Healthcare Sector

ETFs’ Next Act: From Access to Selection